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e thank Dr. Falk for his interest in our study (1) and for directing
s to these earlier published data on the association between driving
nd ventricular arrhythmias. As Dr. Falk points out, the majority of
he arrhythmias in the prior studies seemed to be stress-induced
2–4), and most occurred in patients with active ischemia (4).
lthough the majority of implantable cardioverter-defibrillator (ICD)
atients in the TOVA (Triggers Of Ventricular Arrhythmias) study
opulation had a history of coronary artery disease (n 802; 73.6%),
nly 12% of participants reported experiencing any angina at baseline.
herefore, as Dr. Falk surmised, the number of patients with active
schemia in this ICD population is quite low. Therefore, it is
otentially possible that a higher rate of ventricular arrhythmias might
e observed in patients with active ischemia. Unfortunately, the small
umber of patients with active ischemia in our study limited our
bility to perform this important subgroup analysis. It is also of
nterest that the majority of the rhythm disturbances in these earlier
tudies occurred during the driving episode (2–4) itself as opposed to
hose in our study, which occurred after (1), suggesting that interme-
iary mechanisms, such as exposure to air pollution, might play a
reater role in the precipitation of ventricular arrhythmias associated
ith driving in more recent times. We agree about the enduring value
f historic studies, and to paraphrase another famous quotation,
History is the present. That’s why every generation writes it anew.”
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he Timing of Thrombolysis
or Strokes Complicating
ardiac Catheterization
e read with great interest the article by Khatri et al. (1)
escribing the first systematic study of cerebrovascular accidents
omplicating cardiac catheterization.
In one of the largest single-center series of strokes complicating
ardiac catheterization (2), we report how immediate on-table an-
iography was the key strategy to successful treatment in most ratients. Four patients were treated with intra-arterial thrombolysis, 1
y mechanical reperfusion, and the last with prolonged intravenous
nfusion of abciximab. In the 2 patients in whom a neuroimaging
trategy was adopted before intervention, inferior outcomes were
bserved. In particular, the only hemorrhagic transformation followed
y death was observed in 1 of the 2 patients in whom a thrombolytic
gent was administered more than 180 min after the event with the
elay to allow brain magnetic resonance imaging.
Clearly with such small numbers, definitive demonstration of the
uperiority of immediate intervention over a neuroimaging strategy is
ot possible; however, we feel that “an expedited cerebral CT or
agnetic resonance imaging scan to evaluate for possible intracerebral
emorrhage” as advocated by Lyden (3) may not be the best option in
his setting. In strokes occurring in the general population, delay in
hrombolysis is an important predictor of hemorrhagic transforma-
ion, and strokes complicating cardiac catheterization are unlikely to
epresent an exception to this rule. To this regard it is interesting to
ote that in the report by Khatri et al. (1) the median delay in
ntra-arterial lysis was 240 min, whereas only a 90-min delay occurred
efore intravenous therapy. It would be interesting to know in which
roup the 3 asymptomatic hemorrhages occurred.
We suggest that immediate on-table angiography might be a
ood time-saving and brain-saving point to include in the catheter
aboratory Code Stroke protocol.
Federico De Marco, MD
elen Routledge, MD, MRCP
hierry Lefèvre, MD, FESC
Institut Cardiovasculaire Paris Sud
Avenue du Noyer Lambert
1300 Massy
rance
-mail: federico.demarco@gmail.com
doi:10.1016/j.jacc.2008.03.057
EFERENCES
. Khatri P, Taylor RA, Palumbo V, et al., Treatment of Acute Stroke
After Cardiac Catheterization (TASCC) Study Group. The safety and
efficacy of thrombolysis for strokes after cardiac catheterization. J Am
Coll Cardiol 2008;51:906–11.
. De Marco F, Fernandez-Diaz JA, Lefèvre T, et al. Management of
cerebrovascular accidents during cardiac catheterization: immediate
cerebral angiography versus early neuroimaging strategy. Catheter
Cardiovasc Interv 2007;70:560–8.
. Lyden PD. Code stroke in the cath lab. J Am Coll Cardiol 2008;51:912.
eply
e thank Drs. De Marco, Routledge, and Lefèvre for their
nterest in our work (1). They raise the important question of
hether to take the time to do an imaging study before adminis-
ering cerebral reperfusion therapy in the setting of stroke after
ardiac catheterization. They have proposed immediate acute
troke treatment, transitioning directly from cardiovascular to
erebral angiography for intra-arterial therapy, for strokes after
ardiac catheterization on the table. However, the limited reports
n this topic are likely subject to a publication bias toward
avorable clinical outcomes.
Even if an embolism is identified on an immediate cerebral
ngiogram, the possibility of an acute hemorrhagic infarction
emains a concern, particularly in the setting of antithrombotics
